Hrt Financial LP Atossa Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.8 - $1.89 $233,136 - $550,785	291,421 New	291,421 $524,000
Q3 2023 Nov 13, 2023	BUY	$0.74 - $1.35 $21,562 - $39,336	29,138 New	29,138 $21,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $1.28 $25,418 - $38,277	29,904 New	29,904 $32,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $389,606 - $796,258	-243,504 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $703,726 - $1.56 Million	243,504 New	243,504 $793,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.